Hungary to provide chickenpox vaccine free of charge from next January

12 March 2018
hungary_flag-1-

János Lázár, the Minister heading the Prime Minister of Hungary’s Office announced at a Kormányinfó (government information) event that, from January 1, 2019, the varicella (chickenpox) vaccine will be included among the age-related vaccines provided free of charge, which is another major step in the fight against the disease associated with severe complications in some cases.

The Hungarian Association of Innovative Pharmaceutical Manufacturers (AIPM) welcomes the government’s decision which further broadens the immunity of young children against communicable diseases. In addition to this decision, constructive consultations on the inclusion of other innovative medicinal products in the social security subsidy system have also been held. The AIPM hopes that once these consultations result in a satisfactory conclusion, the advanced therapies having been included in the waiting list so far, will become available to many patients.

Within the framework of the National Immunization Program, the varicella vaccine will be added to the group of the age-related vaccines. Varicella vaccines should be administered in two doses, between the ages of 15 and 18 months.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK

Today's issue

Company Spotlight





More Features in Pharmaceutical